Small Cell Ovarian Carcinomas - Characterisation of Two Rare Tumor Entities

Area of Science:

• Gynecologic Oncology
• Pathology
• Oncology

Background:

• Small cell ovarian carcinoma (SCOC) comprises hypercalcaemic (SCOCHT) and pulmonary (SCOCPT) types.
• Pulmonary-type SCOC (SCOCPT) is poorly understood.
• Differentiating SCOC subtypes is crucial for appropriate management.

Purpose of the Study:

• To systematically analyze and characterize pulmonary-type small cell ovarian carcinoma (SCOCPT).
• To compare clinical and pathological features of SCOCPT with hypercalcaemic-type (SCOCHT).
• To review treatment strategies and outcomes for SCOCPT.

Main Methods:

• Systematic literature review of individual SCOCHT and SCOCPT cases.
• Immunohistochemical analysis using vimentin and chromogranin.
• Analysis of tumor associations, surgical resection rates, and survival data.

Main Results:

• SCOCPT patients were significantly older than SCOCHT patients.
• Vimentin and chromogranin immunohistochemistry aided differentiation.
• SCOCPT was associated with other ovarian tumors in 44% of cases.
• Despite high R0/R1 resection rates (~74%), survival was poor with a 40% recurrence rate in early-stage disease.
• Chemotherapy with etoposide or anthracyclines may be beneficial.

Conclusions:

• SCOCPT exhibits distinct clinical and pathological features compared to SCOCHT.
• Treatment for SCOCPT should align with protocols for other small cell carcinomas.
• Surgery is indicated for early stages, but chemotherapy is essential.
• Somatostatin analogues may offer symptomatic control and tumor stabilization.